Patients and healthcare professionals are reminded to report any suspected adverse reactions to medicines, including those experienced within clinical trials, via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or through the Yellow Card app
Available from: Rentzeperi E, Pegiou S, Koufakis T, et al Sex differences in response to treatment with glucagon-like peptide 1 receptor agonists: opportunities for a tailored approach to diabetes and obesity care
However, observational studies cannot exclude the possibility that elevated homocysteine levels may be associated with confounding variables such as unhealthy lifestyles and other established risk factors, rather than being causally related to vascular disease
They are discussed for overlapping reasons, but they come from different biological concepts, are studied through different mechanisms, and raise different safety and regulatory questions
doi: 10.1007/s10565-023-09790-0 53 ZhengSZhangKZhangYHeJOuyangYLangRet al
